logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Hemostemix PR

Peter Lacey Increases His Investment in Hemostemix Inc.

Jun 21, 2021

HempFusion PR

HempFusion Announces New Chief Financial Officer

Jun 18, 2021

Hemostemix PR

Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

Jun 11, 2021

HempFusion PR

HempFusion Launches Probulin Probiotics in Ireland’s Top Retailer

Jun 10, 2021

HempFusion PR

HempFusion Launches Private Label Business Division, Awarded 10 SKU Private Label Deal with Leading National Retailer

Jun 3, 2021

Hemostemix PR

Hemostemix Announces that, Due to the COVID-19 Pandemic, the Annual and Special Meeting Will Only Be Held via Zoom and Shareholders are Requested to Follow the Meeting Instructions Mailed to the Shareholders of Record

May 31, 2021

Hemostemix PR

Hemostemix Announces the TSX Venture’s Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

May 29, 2021

中国国药集团新冠疫苗的预防效力超过70%

Sinopharm’s Covid-19 Vaccines Top 70% Efficacy, Study Shows

May 28, 2021

Life Science

HempFusion PR

HempFusion CBD and Probulin Probiotics Partner with Two-Time Olympic Gold Medalist and Five-Time World Champion, Kaillie Humphries

May 27, 2021

Life Science

Hemostemix PR

Hemostemix to Present at the Emerging Growth Conference

May 25, 2021

Life Science

HempFusion PR

HempFusion Signs Definitive Agreement to Acquire Leading CBD Brand Sagely Naturals

May 25, 2021

Life Science

HempFusion PR

HempFusion Commends the Proposed Hemp Access and Consumer Safety Act

May 21, 2021

Life Science

HempFusion PR

HempFusion Reports Q1, 2021 Financial Results

May 17, 2021

Life Science

HempFusion PR

HempFusion Wellness Inc. Announces 2021 AGM Voting Results

May 17, 2021

Life Science

HempFusion PR

HempFusion Signs Definitive Agreement to Acquire Pioneering CBD Brand Apothecanna

May 17, 2021

Life Science

HempFusion PR

HempFusion Accelerates International Sales with United Arab Emirates Reopening

May 12, 2021

Life Science

HempFusion PR

HempFusion Wellness Inc. To Report First Quarter 2021 Earnings and Host Conference Call on May 17, 2021

May 11, 2021

Life Science

Hemostemix PR

Hemostemix Announces Closing of Unit Private Placement

May 10, 2021

Life Science

  • ‹‹ Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada